Actinium Pharmaceuticals, Inc. (ATNM)

1.780.01 (-0.56%)

Actinium Pharmaceuticals, Inc. (ATNM) stock comprehensive Cash Flow Analysis including operating cash flow, investing cash flow, financing cash flow, free cash flow, cash flow from operations, cash flow from investing, cash flow from financing. Compare cash flow against peers/competitors, industry and sector standards.

High Bankruptcy RiskBelow Average ESGFair ValuationLow ProfitabilityAdequate Financial HealthInefficient OperationsModerate GrowthLow QualityAdequate Dividend ProfileIndustry Rank: 20.71%Sector Rank: 20.27%

AMEX - Healthcare - Biotechnology | Market Cap: 55.53M | Next Earnings Date: 13 Nov 2025

Day's Range

1.75 - 1.81

52-Week Range

1.03 - 2.41

Volume

122.5K / 297.6K (Avg.)

P/E Ratio | EPS

-1.36 | -1.31

Trending:

ATNM Cash Flow Analysis

Compare against a Competitor

None AGEN AVXL RVPH AXSM TRAW

Reveals whether the business's core operations generate sufficient cash to cover expenses, fund growth, and return capital to shareholders. Sustainable free cash flow is often a key indicator of long-term value creation.

Operating Cash Flow per Share

0.08

Increased from previous period

OCF/share below $1 – Weak cash generation. Howard Marks would be cautious, demanding deeper diligence of liquidity.

Free Cash Flow per Share

0.08

Increased from previous period

FCF/share below $0.5 – Very weak. Howard Marks would consider liquidity risks and heavy capital demands.

Capex-to-Operating Cash Flow

No Data

No Data available this quarter, please select a different quarter.

Income Quality Ratio (OCF / Net Income)

1.12

Increased from previous period

1.0–1.2 ratio – Minimal cushion. Philip Fisher would watch for signs of slipping cash conversion.

Operating Cash Flow-to-Sales Ratio

No Data

No Data available this quarter, please select a different quarter.

+ Add New Metric (Coming Soon)

Add more metric or remove existing ones, customize as per your preference, feature coming soon!

Select Chart Metric:

ATNM Cash Flow Analysis

Compare against a Competitor

None AGEN AVXL RVPH AXSM TRAW

Operating Cash Flow per Share

0.08

Increased from previous period

OCF/share below $1 – Weak cash generation. Howard Marks would be cautious, demanding deeper diligence of liquidity.

Free Cash Flow per Share

0.08

Increased from previous period

FCF/share below $0.5 – Very weak. Howard Marks would consider liquidity risks and heavy capital demands.

Capex-to-Operating Cash Flow

No Data

No Data available this quarter, please select a different quarter.

Income Quality Ratio (OCF / Net Income)

1.12

Increased from previous period

1.0–1.2 ratio – Minimal cushion. Philip Fisher would watch for signs of slipping cash conversion.

Operating Cash Flow-to-Sales Ratio

No Data

No Data available this quarter, please select a different quarter.

+ Add New Metric (Coming Soon)

Add more metric or remove existing ones, customize as per your preference, feature coming soon!

Select Chart Metric: